(Press-News.org) ROCHESTER, NY, May 2, 2024 – Empire Discovery Institute (EDI) has entered into a collaborative research partnership with the National Multiple Sclerosis Society and its commercial development program Fast Forward, LLC. Through a competitive application and review process, EDI was awarded $791,933 from Fast Forward along with technical support from its network of key opinion leaders in multiple sclerosis (MS) who will help contribute to the advancement of EDI’s technology.
Fast Forward provides research funding to commercial entities who develop promising new therapies for the treatment of MS, a demyelinating disease of the central nervous system impacting the brain, spinal cord and optic nerves. EDI has been incubating an early-stage drug discovery project that originated from University at Buffalo collaborator M. Laura Feltri MD, an internationally renowned pioneer in the study and treatment of myelin diseases of the nervous system. Dr. Feltri and the EDI scientific team discovered novel small molecules which have the potential to stimulate the repair of nerve damage by promoting remyelination in MS and other white matter injuries. The Fast Forward award will support continued optimization of these small molecule drug candidates.
“We look forward to working with our National MS Society partners at Fast Forward to advance this work toward human clinical studies. By combining scientific innovation and pharmaceutical industry expertise, EDI’s goal of promoting the efficient translation of fundamental scientific discoveries from academia into important new medicines is becoming reality,” said Ron Newbold, CEO of Empire Discovery Institute.
EDI was saddened to learn of the passing of Dr. M. Laura Feltri in late 2023 after a long battle with cancer, but plan to continue the work she guided throughout her storied career.
"Empire Discovery Institute is deeply grateful to Fast Forward for their support," says Venu Govindaraju, EDI board member and vice president of research and economic development at UB. "We are honored by this award and look forward to continuing esteemed colleague Dr. Feltri's life's achievements, legacy and the institute's important work in advancing drug treatments for MS patients around the world."
For Fast Forward, this partnership represents a continuation of its dedication to support novel research efforts aimed at advancing promising treatments for MS patients.
“Fast Forward is pleased to provide significant financial and intellectual support to this Empire Discovery Institute program, as it offers the potential to slow or stop the progression of demyelination in people who have progressive forms of MS” said Dr. Walt Kostich, Associate Vice President, Translational Research at the National MS Society. “We look forward to collaborating with EDI on this program as it aligns closely with the Pathways to Cures Roadmap, in particular to stop progression and to promote myelin repair and protection.”
About Multiple Sclerosis
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
About the National Multiple Sclerosis Society
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, X, formerly known as Twitter, Instagram, YouTube or 1-800-344-4867.
About Empire Discovery Institute
Empire Discovery Institute (EDI) is a non-profit New York drug discovery and development accelerator created to translate promising scientific discoveries into new break-through treatments and cures, support vital upstate NY pharmaceutical research efforts, and foster the development of a vibrant biotech start-up community within New York State. EDI leverages an Advisory Board of world-class scientific, technical and business development veterans who have an established track record of translating discoveries through the early stages of development to clinical proof of concept and commercialization. EDI serves as an important bridge across the “valley of death” that traditionally divides academic innovation from commercial translation. EDI has been made possible through a New York State seed grant from Empire State Development and through a research partnership with the University at Buffalo, University of Rochester and Roswell Park Comprehensive Cancer Center. (www.discoverEDI.org)
END
Empire Discovery Institute receives commercial funding award from the National Multiple Sclerosis Society
2024-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Nicola Fuchs-Schündeln to become the new President of the WZB Berlin Social Science Center
2024-05-02
The shareholders' meeting of the WZB has appointed Nicola Fuchs-Schündeln as the institute's future president. She succeeds Jutta Allmendinger, who has headed the institute since 2007. Nicola Fuchs-Schündeln is Professor of Macroeconomics and Development at Goethe University Frankfurt. The handover of office will take place on September 4, 2024 at the WZB.
Nicola Fuchs-Schündeln is a nationally and internationally renowned scientist who returned to Germany in 2009 after several years at Yale and Harvard. Since then, ...
Toxic chemicals can be detected with new AI method
2024-05-02
Swedish researchers at Chalmers University of Technology and the University of Gothenburg have developed an AI method that improves the identification of toxic chemicals – based solely on knowledge of the molecular structure. The method can contribute to better control and understanding of the ever-growing number of chemicals used in society, and can also help reduce the amount of animal tests.
The use of chemicals in society is extensive, and they occur in everything from household products to industrial processes. Many chemicals reach our waterways and ecosystems, where they may cause negative effects on humans and other ...
The people who are most active on social media are also the most active offline
2024-05-02
Parents often worry about the use of social media among children and young people. Caring about this is a good thing, and there are several reasons why you should pay attention, but there is one thing that parents needn’t worry about: young people spending time on social media does not impair their interaction with friends offline, according to a new study.
“On the contrary, we find that people who use social media a lot spend more time with friends offline,” says Professor Silje Steinsbekk at the Norwegian University of Science and Technology (NTNU’s) Department of Psychology.
The results are ...
Climate is one culprit in spread and growth of dust in Middle East
2024-05-02
Climate change is transforming dust storms—a natural phenomenon in the Middle East—into a more frequent and widespread threat to health and economies throughout the region, a new study shows.
Dust levels have increased in many parts of the Middle East chiefly due to global warming, but other human activities also share credit, says Zahra Kalantari, associate professor at KTH Royal Institute of Technology. She cites such factors as oil extraction, military conflicts and lack of cross-border ...
Gene signatures from tissue-resident T cells as a predictive tool for melanoma patients
2024-05-02
(LOS ANGELES) – May 2, 2024 - An extensive analytical study conducted at the Terasaki Institute for Biomedical Innovation (TIBI) has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations of tissue-resident memory T cells (TRM). Data obtained from this study could be used not only for a TRM-based machine learning model with predictive powers for melanoma prognosis but could also elucidate the role TRM cells can play in the tumor immune microenvironment. This could guide the development of more effective and personalized anti-tumor immunotherapeutic treatment regimens for cancer ...
FAU creates new Department of Biomedical Engineering
2024-05-02
In recognition of a rapidly growing field, Florida Atlantic University’s College of Engineering and Computer Science (COECS) has created a Department of Biomedical Engineering. The newly established department will focus on three key areas: biomaterials and tissue engineering; smart health systems; and bio-robotics. Biomedical engineering integrates fundamental and practical concepts in electrical and mechanical engineering, biology, computer science and medicine into a cross-disciplinary field focused on improving human health and solving problems in the delivery of health care.
The COECS faculty are already performing ...
Program announced for NUTRITION 2024 to be held June 29–July 2
2024-05-02
Reporters are invited to join leading nutrition researchers and professionals at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition. The meeting will bring together thousands of experts from around the globe to share and discuss emerging scientific and policy developments in food, nutrition and public health June 29–July 2 in Chicago.
The meeting program features exciting scientific symposia, award lectures, networking events and more, offering an up-close view into the latest findings, opportunities and debates. More than 1,600 original research studies will be presented ...
A link between breast changes and … UTIs?
2024-05-02
Women’s health is often talked about in terms of major, life-altering events like pregnancy and menopause. A new study from Cold Spring Harbor Laboratory (CSHL) underscores the importance of considering everyday occurrences’ impact on women’s well-being.
CSHL researchers have made a surprising discovery involving urinary tract infections (UTIs). The scientists found that UTIs in mice can provoke a bodily response that results in structural changes in breast tissue. Remarkably, these changes are reversible ...
Researchers create new chemical compound to solve 120-year-old problem
2024-05-02
MINNEAPOLIS/ST. PAUL (05/02/2024) — For the first time, chemists in the University of Minnesota Twin Cities College of Science and Engineering have created a highly reactive chemical compound that has eluded scientists for more than 120 years. The discovery could lead to new drug treatments, safer agricultural products, and better electronics.
For decades, researchers have been investigating molecules called N-heteroarenes, which are ring-shaped chemical compounds that contain one or more nitrogen atoms. Bio-active molecules having a N-heteroarene core are widely ...
Four state-of-the-art, artificial intelligence search engines for histopathology images may not be ready for clinical use
2024-05-02
Four proposed state-of-the art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, new research suggests.
The performance of the artificial intelligence algorithms to power the histopathology image databases was worse than expected, with some having less than 50% accuracy, which is not suitable for clinical practice, said Dr. Helen Shang, a third-year internal medicine resident and incoming hematology-oncology fellow at the David Geffen School ...